Display Settings:

Format

Send to:

Choose Destination
    Curr Gastroenterol Rep. 2005 May;7(2):114-21.

    Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome.

    Source

    Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1804, USA.

    Abstract

    Gastrinomas producing Zollinger-Ellison syndrome are the most frequent symptomatic, malignant pancreatic endocrine tumor syndrome. Recently, a number of important studies have examined their molecular pathogenesis and natural history and provided important guidelines for their treatment. Each of these areas is briefly reviewed in this article.

    PMID:
    15802099
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk